share_log

4: Statement of changes in beneficial ownership of securities-Officer Dogan Meeshanthini

4: Statement of changes in beneficial ownership of securities-Officer Dogan Meeshanthini

4：持股變動聲明-高管 Dogan Meeshanthini
美股SEC公告 ·  09/09 23:05

牛牛AI助理已提取核心訊息

Cardio Diagnostics Holdings, Inc. CEO Dogan Meeshanthini completed a purchase of company stock on September 6, 2024. The transaction involved the acquisition of 68,965 shares of common stock at a price of $0.29 per share. Following this transaction, Meeshanthini's direct holdings in the company increased to a total of 1,683,867 shares. The transaction, which took place in the open market, reflects the CEO's direct investment in the company's equity.
Cardio Diagnostics Holdings, Inc. CEO Dogan Meeshanthini completed a purchase of company stock on September 6, 2024. The transaction involved the acquisition of 68,965 shares of common stock at a price of $0.29 per share. Following this transaction, Meeshanthini's direct holdings in the company increased to a total of 1,683,867 shares. The transaction, which took place in the open market, reflects the CEO's direct investment in the company's equity.
Cardio Diagnostics Holdings, Inc.首席執行官Dogan Meeshanthini於2024年9月6日完成了一筆公司股票的購買。這筆交易涉及以每股0.29美元的價格收購68,965股普通股。在此次交易之後，Meeshanthini在公司的直接持股增至總計1,683,867股。這筆交易在開放市場上進行，反映了首席執行官對公司股權的直接投資。
Cardio Diagnostics Holdings, Inc.首席執行官Dogan Meeshanthini於2024年9月6日完成了一筆公司股票的購買。這筆交易涉及以每股0.29美元的價格收購68,965股普通股。在此次交易之後，Meeshanthini在公司的直接持股增至總計1,683,867股。這筆交易在開放市場上進行，反映了首席執行官對公司股權的直接投資。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間